Figure 3 | Scientific Reports

Figure 3

From: Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis

Figure 3

Network meta-analysis of different time-points of perioperative anti-VEGF treatment compared with sham treatment for the primary outcomes: (A) Post-operative BCVA; (B) Incidence of recurrent VH. Pre-Op pre-operative, PPV pars plana vitrectomy, VH vitreous hemorrhage, BCVA best-corrected visual acuity.

Back to article page